(MFC) Manulife Financial - NYSE
Sector: Financial Services | Industry: Insurance - Life | Exchange: NYSE (USA) | Market Cap: 67.643m USD | Total Return: 30.9% in 12m
Avg Turnover: 82.3M
EPS Trend: 89.0%
Qual. Beats: 0
Rev. Trend: 4.9%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Manulife Financial Corporation (MFC) is a diversified financial services provider headquartered in Toronto, operating primarily across North America and Asia. The company’s business model is structured into three main pillars: Wealth and Asset Management, Insurance and Annuity Products, and a Corporate segment that oversees reinsurance and legacy run-off operations. Beyond core life and health insurance, Manulife maintains a specialized presence in alternative long-term assets, including the management of timberland and agricultural portfolios.
The Life & Health Insurance sector is characterized by a high degree of sensitivity to interest rate fluctuations and credit spreads, which impact both investment yields and long-term liability valuations. As a global provider, Manulife utilizes a multi-channel distribution strategy that leverages independent brokers, financial planners, and institutional partnerships to scale its retail and retirement solutions. The company’s integrated banking services and asset management arm further diversify its revenue streams beyond traditional underwriting premiums.
Investors can further examine these financial metrics and valuation trends by visiting ValueRay.
- Asian market expansion drives core earnings growth and long-term revenue diversification
- Rising interest rates increase investment yields and improve life insurance margins
- Wealth and asset management inflows boost fee-based revenue and capital efficiency
- Management of long-term care legacy liabilities impacts capital reserve requirements
- Global equity market performance dictates assets under management and advisory income
| Net Income: 6.42b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.10 > 1.0 |
| NWC/Revenue: 100.5% < 20% (prev -837.0%; Δ 937.5% < -1%) |
| CFO/TA 0.03 > 3% & CFO 29.0b > Net Income 6.42b |
| Net Debt (-1.08b) to EBITDA (10.3b): -0.11 < 3 |
| Current Ratio: error (cannot be calculated; needs correct Total Current Assets and Liabilities) |
| Outstanding Shares: last quarter (1.71b) vs 12m ago -1.21% < -2% |
| Gross Margin: 50.23% > 18% (prev 77.80%; Δ -27.57% > 0.5%) |
| Asset Turnover: 7.89% > 50% (prev 4.72%; Δ 3.17% > 0%) |
| Interest Coverage Ratio: 6.10 > 6 (EBIT TTM 9.41b / Interest Expense TTM 1.54b) |
| A: 0.08 (Total Current Assets 79.8b - Total Current Liabilities 0.0) / Total Assets 1029b |
| B: 0.00 (Retained Earnings 5.04b / Total Assets 1029b) |
| C: 0.01 (EBIT TTM 9.41b / Avg Total Assets 1005b) |
| D: 0.05 (Book Value of Equity 50.8b / Total Liabilities 976b) |
| Altman-Z'' = 0.64 = B |
| DSRI: 3.0 (Receivables 65.2b/2.51b, Revenue 79.3b/46.3b) |
| GMI: 1.55 (GM 77.80% / 50.23%) |
| AQI: 0.95 (AQ_t 0.92 / AQ_t-1 0.97) |
| SGI: 1.71 (Revenue 79.3b / 46.3b) |
| TATA: -0.02 (NI 6.42b - CFO 29.0b) / TA 1029b) |
| Beneish M = -0.41 (Cap -4..+1) = D |
As of June 25, 2026, the stock is trading at USD 39.70 with a total of 1,569,651 shares traded. Over the past week, the price has changed by -3.45%, over one month by +3.86%, over three months by +16.38% and over the past year by +30.91%.
Current recommended Stop Loss: 38.20 (which is 3.8% or 2 ATR below the current price).
Manulife Financial has received a consensus analysts rating of 3.77. Therefore, it is recommended to hold MFC.
- StrongBuy: 3
- Buy: 5
- Hold: 4
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 33.6 | -15.3% |
Market Cap CAD = 96.1b (67.6b USD * 1.421 USD.CAD)
P/E Trailing = 16.375
P/E Forward = 12.8041
P/S = 2.1119
P/B = 2.1114
P/EG = 0.7785
Revenue TTM = 79.3b CAD
EBIT TTM = 9.41b CAD
EBITDA TTM = 10.3b CAD
Long Term Debt = 13.1b CAD (from longTermDebt, last quarter)
Short Term Debt = 377.0m CAD (from shortLongTermDebt, last quarter)
Debt = 13.5b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.08b CAD (calculated: Debt 13.5b - CCE 14.6b)
Enterprise Value = 95.0b CAD (96.1b + Debt 13.5b - CCE 14.6b)
Interest Coverage Ratio = 6.10 (Ebit TTM 9.41b / Interest Expense TTM 1.54b)
EV/FCF = 3.28x (Enterprise Value 95.0b / FCF TTM 29.0b)
FCF Yield = 30.47% (FCF TTM 29.0b / Enterprise Value 95.0b)
FCF Margin = 36.49% (FCF TTM 29.0b / Revenue TTM 79.3b)
Net Margin = 8.09% (Net Income TTM 6.42b / Revenue TTM 79.3b)
Gross Margin = 50.23% ((Revenue TTM 79.3b - Cost of Revenue TTM 39.5b) / Revenue TTM)
Gross Margin QoQ = none% (prev 76.01%)
Tobins Q-Ratio = 0.09 (Enterprise Value 95.0b / Total Assets 1029b)
Interest Expense / Debt = 11.44% (Interest Expense 1.54b / Debt 13.5b)
Taxrate = 15.11% (1.19b / 7.86b)
NOPAT = 7.98b (EBIT 9.41b * (1 - 15.11%))
Current Ratio = unknown (Total Current Assets 79.8b / Total Current Liabilities 0.0)
Debt / Equity = 0.27 (Debt 13.5b / totalStockholderEquity, last quarter 50.8b)
Debt / EBITDA = -0.11 (Net Debt -1.08b / EBITDA 10.3b)
Debt / FCF = -0.04 (Net Debt -1.08b / FCF TTM 29.0b)
Total Stockholder Equity = 50.8b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.64% (Net Income 6.42b / Total Assets 1029b)
RoE = 12.65% (Net Income TTM 6.42b / Total Stockholder Equity 50.8b)
RoCE = 14.74% (EBIT 9.41b / Capital Employed (Equity 50.8b + L.T.Debt 13.1b))
RoIC = 0.93% (EBIT 9.41b / (Assets 1029b - Curr.Liab 0.0 - Cash 14.6b))
WACC = 9.11% (E(96.1b)/V(110b) * Re(9.03%) + D(13.5b)/V(110b) * Rd(11.44%) * (1-Tc(0.15)))
Discount Rate = 9.03% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -88.66 | Cagr: -4.17%
[DCF] Terminal Value 72.97% ; FCFF base≈28.8b ; Y1≈29.2b ; Y5≈31.6b
[DCF] Fair Price = 261.1 (EV 434b - Net Debt -1.08b = Equity 435b / Shares 1.67b; r=9.11% [WACC]; 5y FCF grow 1.22% → 2.50% )
EPS Correlation: 89.05 | EPS CAGR: 7.48% | SUE: -0.42 | # QB: 0
Revenue Correlation: 4.87 | Revenue CAGR: 1.32% | SUE: 0.34 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.09 | Chg30d=-2.39% | Revisions=-54% | Analysts=10
EPS next Quarter (2026-09-30): EPS=1.17 | Chg30d=-0.69% | Revisions=-50% | Analysts=10
EPS current Year (2026-12-31): EPS=4.48 | Chg30d=-0.95% | Revisions=-60% | GrowthEPS=+6.3% | GrowthRev=-5.6%
EPS next Year (2027-12-31): EPS=4.94 | Chg30d=-0.49% | Revisions=-50% | GrowthEPS=+10.3% | GrowthRev=-7.8%
[Analyst] Revisions Ratio: -60%